Insider · CIK 0001717580
Linda Palczuk
Files at AVDL (AVADEL PHARMACEUTICALS PLC). First filing Dec 10, 2024, latest Jan 22, 2025.
In brief
Linda Palczuk files SEC Form 4 as director at AVDL (AVADEL PHARMACEUTICALS PLC). Since Dec 10, 2024, Linda Palczuk has reported 2 open-market buys worth $70k and 0 open-market sells worth $0, the latest filed on Jan 22, 2025.
A track record needs three past buys with six months of prices behind them; Linda Palczuk has 0, so none is measured yet.
The newest scored trade: bought $40k of AVDL on Jan 21, 2025, filed Jan 22, 2025, scored 44 (moderate).
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 44Moderate | AVADEL PHARMACEUTICALS PLC | $40k 5,000 shares | +8% | - | |
| 35Weak | AVADEL PHARMACEUTICALS PLC | $31k 3,000 shares | +5% | - |
Transactions
Every row this insider has filed, 17 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 12, 2026 | AVDL AVADEL PHARMACEUTICALS PLC | DDisposition to issuer Ordinary Shares | -78,905 | $21.00 | $1.7M | 0 | Feb 12, 2026 |
| Feb 12, 2026 | AVDL AVADEL PHARMACEUTICALS PLC | DDisposition to issuer Stock Option (Right to Buy)derivativeindirect: By Trust | -60,000 | - | - | 0 | Feb 12, 2026 |
| Feb 12, 2026 | AVDL AVADEL PHARMACEUTICALS PLC | DDisposition to issuer Stock Option (Right to Buy)derivativeindirect: By Trust | -42,000 | - | - | 0 | Feb 12, 2026 |
| Feb 12, 2026 | AVDL AVADEL PHARMACEUTICALS PLC | DDisposition to issuer Stock Option (Right to Buy)derivativeindirect: By Trust | -42,000 | - | - | 0 | Feb 12, 2026 |
| Feb 12, 2026 | AVDL AVADEL PHARMACEUTICALS PLC | DDisposition to issuer Stock Option (Right to Buy)derivativeindirect: By Trust | -42,000 | - | - | 0 | Feb 12, 2026 |
| Feb 12, 2026 | AVDL AVADEL PHARMACEUTICALS PLC | DDisposition to issuer Stock Option (Right to Buy)derivativeindirect: By Trust | -33,000 | - | - | 0 | Feb 12, 2026 |
| Feb 12, 2026 | AVDL AVADEL PHARMACEUTICALS PLC | DDisposition to issuer Stock Option (Right to Buy)derivativeindirect: By Trust | -11,000 | - | - | 0 | Feb 12, 2026 |
| Feb 12, 2026 | AVDL AVADEL PHARMACEUTICALS PLC | DDisposition to issuer Stock Option (Right to Buy)derivativeindirect: By Trust | -25,000 | - | - | 0 | Feb 12, 2026 |
| Feb 12, 2026 | AVDL AVADEL PHARMACEUTICALS PLC | DDisposition to issuer Stock Option (Right to Buy)derivativeindirect: By Trust | -11,000 | - | - | 0 | Feb 12, 2026 |
| Sep 15, 2025 | AVDL AVADEL PHARMACEUTICALS PLC | GGift Stock Option (Right to Buy)derivative | -11,000 | $0.00 | $0 | 0 | Sep 15, 2025 |
| Jul 29, 2025 | AVDL AVADEL PHARMACEUTICALS PLC | AGrant or award Ordinary Shares | +11,000 | $0.00 | $0 | 78,900 | Jul 31, 2025 |
| Jul 29, 2025 | AVDL AVADEL PHARMACEUTICALS PLC | AGrant or award Stock Option (Right to Buy)derivative | +11,000 | $0.00 | $0 | 11,000 | Jul 31, 2025 |
| Jan 24, 2025 | AVDL AVADEL PHARMACEUTICALS PLC | GGift Stock Option (Right to Buy)derivative | -25,000 | $0.00 | $0 | 0 | Jan 28, 2025 |
| Jan 21, 2025 | AVDL AVADEL PHARMACEUTICALS PLC | POpen-market purchase Ordinary Shares | +5,000 | $7.93 | $40k | 67,900 | Jan 22, 2025 |
| Dec 24, 2024 | AVDL AVADEL PHARMACEUTICALS PLC | GGift Ordinary Shares | -3,500 | $0.00 | $0 | 62,900 | Dec 27, 2024 |
| Dec 17, 2024 | AVDL AVADEL PHARMACEUTICALS PLC | AGrant or award Stock Option (Right to Buy)derivative | +25,000 | $0.00 | $0 | 25,000 | Dec 19, 2024 |
| Dec 6, 2024 | AVDL AVADEL PHARMACEUTICALS PLC | POpen-market purchase Ordinary Shares | +3,000 | $10.19 | $31k | 66,400 | Dec 10, 2024 |
Questions about Linda Palczuk
Answered from the filings on this page, as of the latest one.
Is Linda Palczuk buying or selling?
Not in the last 12 months. Linda Palczuk's latest open-market trade on SEC Form 4 was bought $40k of AVDL on Jan 21, 2025.
How did Linda Palczuk's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Linda Palczuk has 0.
Where does Linda Palczuk file Form 4?
Linda Palczuk has filed Form 4 at AVDL (AVADEL PHARMACEUTICALS PLC). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.